Abstract Objective To analyze the clinical and immunological features of children with lupus nephritis (LN). Methods Chart records of 40 (4 male and 36 female) LN children who were admitted consecutively between January, 2005 and December, 2010 were reviewed. The baseline demographic, pathological and immunological data were analyzed. Results In the 40 LN patients analyzed, the mean age of the disease onset was 10.6±2.6 (range from 2.6 to 14.3) years, and 35 cases (88%) were school-age children. Proteinuria was detected in all 40 cases, including nephrotic-range proteinuria in 12 (30%) cases, and isolated proteinuria in 9 (22%) cases. Twenty-six (65%) patients had varying degrees of hematuria. Acute nephritis was the most common sub-type, accounting for 47% of the total cases. Among the 39 cases undergoing renal biopsy, 3 were unclassified and the remaining 36 were classified, respectively, as type Ⅳ LN (50%, 18 cases), type Ⅱ LN (22%, 8 cases). In the histopathologcally classified case, 100% were antinuclear antibody-positive, 61% were anti-dsDNA-positive, and 89% showed varying degrees of decrease in serum C3 and C4 concentrations. Following treatment for 6 months, a high LN remission rate (95%) was achieved; the acute renal activity index remained higher in Ⅳ, V+Ⅲ and V+Ⅳ subtypes than in other subtypes, while the chronic index and the degree of tubulointerstitial damage were not different between histopathological subtypes. Conclusions The clinical manifestations of LN children are diverse. Clinically, acute nephritis is the most common form of LN in children. Histopathologically, type Ⅳ is the most frequent subtype of LN. Early treatment may result in significant disease remission.
CHENG Xue-Qin,BAO Hua-Ying,ZHANG Ai-Hua et al. Clinical and immunological features of lupus nephritis in children：retrospective analysis of 40 cases[J]. CJCP, 2014, 16(1): 53-57.
CHENG Xue-Qin,BAO Hua-Ying,ZHANG Ai-Hua et al. Clinical and immunological features of lupus nephritis in children：retrospective analysis of 40 cases[J]. CJCP, 2014, 16(1): 53-57.
Lau KK, Jones DP, Ault BH. Prognosis of lupus membranous nephritis in children[J]. Lupus, 2007, 16(1): 70.
[2]
Ding L, Zhao M, Zou W, et al. Mycophenolate mofetil combined with prednisone for diffuse proliferative lupus nephritis: a histopathological study[J]. Lupus, 2004, 13(2): 113-118.
[3]
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus[J]. Arthritis Rheum, 1997, 40(9): 1725.
Weening JJ, D'Agati VD, Schwartz MM. The classification of glomerulonephritis in systemic lupus erythematosus revisited[J]. Kidney Int, 2004, 65(2): 521-530.
Agarwal I, Kumar TS, Ranjini K, et al. Clinical features and outcome of systemic lupus erythematosus[J]. Indian Pediatr, 2009, 46(8): 711-715.
[11]
Atta AM, Pereira MM, Santiago M, et al. Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis[J]. Clin Rheumatol, 2009, 28(6): 693-697.
